Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/bmri/volume-2018/2703518/figures/2703518.fig.002a.svgz" name="2703518.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>High versus low NLR on CVD risk</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/bmri/volume-2018/2703518/figures/2703518.fig.002b.svgz" name="2703518.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Mean difference of NLR between CVD and non-CVD</td></tr></table>

<div>Summary of pooled effect sizes of neutrophil lymphocyte ratio on cardiovascular risk.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis 